A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
Active, not recruiting · NCT06336291 · Registry updated 2026-04-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-04-21 | NCT06336291 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Philogen S.p.A. | 15 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Abramson Cancer Center of the University of Pennsylvania | Philadelphia | United States | 47 |
| Beth Israel Deaconess Medical Center (Bidmc) | Boston | United States | 14 |
| Dana-Farber Cancer Institute (DFCI) | Boston | United States | 4 |
| Massachusetts General Hospital (MGH) | Boston | United States | 14 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Northwestern Memorial Hospital | Chicago | United States | 129 |
| The University of Texas, MD Anderson Cancer Center | Houston | United States | 11 |
| University of Virginia (UVA) | Charlottesville | United States | 3 |
| UPMC Hillman Cancer Center | Pittsburgh | United States | 330 |